These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15629333)

  • 1. Persistency with glaucoma medication.
    Fiscella RG
    Am J Ophthalmol; 2004 Dec; 138(6):1093-4; author reply 1094. PubMed ID: 15629333
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistency and tolerability of ocular hypotensive agents: population-based evidence in the management of glaucoma.
    Schwartz GF
    Am J Ophthalmol; 2004 Jan; 137(1 Suppl):S1-2. PubMed ID: 14697908
    [No Abstract]   [Full Text] [Related]  

  • 3. Modern alchemy: fixed combinations of glaucoma drugs.
    Katz LJ
    Am J Ophthalmol; 2005 Jul; 140(1):125-6. PubMed ID: 16038653
    [No Abstract]   [Full Text] [Related]  

  • 4. Measuring persistency and intraocular pressure-controlled days in patients receiving topical glaucoma medications.
    Schwartz GF; Platt R
    Am J Manag Care; 2002 Aug; 8(10 Suppl):S278-80. PubMed ID: 12188171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Compliance in glaucoma].
    Stefan C; Dumitrică DM
    Oftalmologia; 2008; 52(3):7-9. PubMed ID: 19149111
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lowering of intraocular pressure with clonidin].
    Edelhauser E; Nemetz U
    Klin Monbl Augenheilkd; 1972 Feb; 160(2):188-93. PubMed ID: 5018069
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of eyedrops in glaucoma: how can we help to reduce non-compliance?
    Chawla A; McGalliard JN; Batterbury M
    Acta Ophthalmol Scand; 2007 Jun; 85(4):464. PubMed ID: 17286557
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glaucoma--strategy of treatment].
    Stefan C; Selaru D; Stefaniu I; Dumitrică DM
    Oftalmologia; 2008; 52(3):3-6. PubMed ID: 19149110
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glaucoma and dry eye. Current concepts and future perspectives].
    Steven P; Cursiefen C
    Ophthalmologe; 2013 Dec; 110(12):1155-9. PubMed ID: 24129917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [General substance classification and pharmacology of glaucoma].
    Thieme H; Renieri G; Schuart C
    Ophthalmologe; 2013 Dec; 110(12):1149-54. PubMed ID: 24337206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A myth of ophthalmic beta-blockers therapy.
    Kittisupamongkol W
    Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1721; author reply 1723. PubMed ID: 19693528
    [No Abstract]   [Full Text] [Related]  

  • 12. [Advances in preservative-free glaucoma drops].
    Stefan C; Pop A; Cojocaru I
    Oftalmologia; 2011; 55(2):3-6. PubMed ID: 21888063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
    Barnebey HS; Orengo-Nania S; Flowers BE; Samples J; Mallick S; Landry TA; Bergamini MV
    Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glaucoma.
    Shah R; Wormald R
    Clin Evid; 2002 Jun; (7):589-96. PubMed ID: 12230685
    [No Abstract]   [Full Text] [Related]  

  • 15. Bimatoprost versus timolol and dorzolamide.
    Tressler CS
    Ophthalmology; 2005 Feb; 112(2):357-8; author reply 358-9. PubMed ID: 15691575
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of primary open angle glaucoma in a case of multiple chemical sensitivity syndrome: a case report].
    Attia M; Fitting A; Auffarth GU; Kretz FT
    Klin Monbl Augenheilkd; 2014 Aug; 231(8):835-6. PubMed ID: 25133561
    [No Abstract]   [Full Text] [Related]  

  • 17. Validation of a short version of the glaucoma medication self-efficacy questionnaire.
    Sleath B; Blalock SJ; Stone JL; Skinner AC; Covert D; Muir K; Robin AL
    Br J Ophthalmol; 2012 Feb; 96(2):258-62. PubMed ID: 21610264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction: new insights on enhancing adherence to topical glaucoma medications.
    Friedman DS
    Ophthalmology; 2009 Nov; 116(11 Suppl):S29. PubMed ID: 19837257
    [No Abstract]   [Full Text] [Related]  

  • 19. Duration of IOP reduction with travoprost BAK-free solution.
    Gross RL; Peace JH; Smith SE; Walters TR; Dubiner HB; Weiss MJ; Ochsner KI
    J Glaucoma; 2008; 17(3):217-22. PubMed ID: 18414108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The deleterious effect of certain surface active agents on the ocular surface].
    Ravet O
    Bull Soc Belge Ophtalmol; 2007; (304):145-9. PubMed ID: 17718239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.